Insiders Updates
MaxCyte Inc (MXCT) gets rating Downgrade from BTIG Research
In a filing, MaxCyte Inc revealed its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25.
Menu
In a filing, MaxCyte Inc revealed its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25.
MaxCyte Inc’s filing revealed that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. In
MaxCyte Inc’s recent filing unveils that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25.
MaxCyte Inc’s recent filing unveils that its CHIEF FINANCIAL OFFICER Swirsky Douglas J acquired Company’s shares for reported $64500.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
MaxCyte Inc’s filing revealed that its CHIEF FINANCIAL OFFICER Swirsky Douglas J acquired Company’s shares for reported $64500.0 on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or